TED Ted Baker Plc

RNS Number:9836H
Tepnel Life Sciences PLC
23 August 2006




FOR IMMEDIATE RELEASE



              Tepnel Life Sciences plc ('Tepnel' or 'the Company')

                 Directors' Interests in Shares of the Company



Manchester, U.K,  23 August 2006 Tepnel Life Sciences PLC (AIM: TED), the
UK-based international Molecular Diagnostics and Research Products & Services
group, today announces that it has developed a new Long Term Incentive Plan
based on the award of share options for executive directors and management. The
plan has been introduced to align more closely management incentives with the
interests of shareholders and links awards to growth in the Company's share
price over the 3 year vesting period. The scheme, which will be known as the
Tepnel Life Sciences Plc 2006 Long Term Incentive Plan, was approved by the
Board on 17 August 2006 ("Long Term Incentive Plan").



Under the terms of the plan, the Company granted 5,000,000 nil cost options to
Ben Matzilevich, Chief Executive Officer on 22 August 2006. The release of the
option awards will be based on the growth in the Company's share price over the
period from the date of grant to the third anniversary of the date of grant in
accordance with the following table:


             Share Price Growth Target                % of Award Released
                        50%                                   25%
                        100%                                  100%

Straight line vesting between points



No awards will be released unless the return on the Company's shares exceeds the
return on the FTSE AIM Index over the same period.  In addition, under the Long
Term Incentive Plan, the Company granted a further 6,165,000 awards on 22 August
2006 to management with the same vesting criteria.



                                     -End-





For Further Information:

Tepnel Life Sciences plc
Ben Matzilevich, CEO
0161 946 2200

De Facto Communications
Richard Anderson
020 7861 3838

Notes to Editors

About Tepnel Life Sciences plc

Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two main divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees.  TLS provides test
kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research.  The company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets.  TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market segments.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSBRGDIGSDGGLD

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024